NIH Board Rebukes Kennedy for Politicizing Vaccine Injury Research

Key points

• Jack Leslie, chair of the NIH Clinical Center board, delivered a six-minute rebuke of Kennedy, warning that political messaging damages the hospital’s 70-year reputation.
• The board unanimously endorsed Leslie’s statement, arguing that Kennedy’s 'vaccine injured' placards pre-judge research outcomes that have not yet been conducted.
• HHS Secretary Kennedy launched a four-part initiative on October 8, including a new NIH clinic, Medicare reimbursement codes, EHR documentation changes, and VAERS modernization.
• NIH Director Jay Bhattacharya clarified that the new Vaccinology and Immunology Center is a research study within an existing facility, not a new clinic, and will not accept walk-in patients.
• Critics, including the Taxpayers Protection Alliance, argue that weakening the Vaccine Injury Compensation Program could drive up costs and hurt vaccine supply.

Background

This controversy follows the October 8 announcement of a comprehensive federal initiative to address vaccine-related injuries. Previous coverage noted that while HHS framed the move as restoring trust, public health experts warned it could exacerbate hesitancy. The current dispute centers on the optics of the October 5 launch event, which featured patients holding signs declaring them 'vaccine injured' before scientific protocols were finalized.

How outlets are covering it

Ars Technica highlights the internal conflict at the NIH, focusing on Jack Leslie’s warning that Kennedy’s actions undermine the 'house of hope' for rare disease patients. The Washington Post opinion piece argues that most voters support vaccine access and that Kennedy’s push to alter the Vaccine Injury Compensation Program is out of step with public sentiment. The NIH’s official statement emphasizes scientific rigor, clarifying that the new center is a research protocol designed to investigate symptoms without pre-determining causation. Nurse.org provides a practical overview for healthcare workers, noting that while the initiative aims to improve reporting, it does not establish that every post-vaccination event is vaccine-caused, and warns that increased reporting does not equal increased causation.

Why it matters

The dispute threatens the credibility of the NIH, a cornerstone of American medical research. If the public perceives that federal research is steered toward political conclusions, trust in scientific findings may erode, potentially affecting vaccine uptake and the integrity of future safety studies. The clash between political messaging and scientific protocol sets a precedent for how government agencies handle public health crises.

What to watch

The NIH is finalizing the study protocol for the Vaccinology and Immunology Center, with launch expected before the end of 2026. CMS is expected to issue the final rule for the proposed Medicare billing code GADV1 in late fall, with potential implementation in January 2027. The board’s unanimous condemnation may lead to further internal reviews of how HHS interacts with NIH facilities.